Skye Bioscience, Inc. (SKYE) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Core Points - The presentation is led by Frank Tang, a Managing Director at Morgan Stanley, indicating a formal engagement with stakeholders [1] - The event features a fireside chat with Skye Bioscience, highlighting the company's leadership presence with CEO Punit Dhillon [2] Company Overview - Skye Bioscience is positioned for discussion, suggesting a focus on its strategic initiatives and market positioning [2] Industry Context - The involvement of a major investment bank like Morgan Stanley suggests significant interest in the biotechnology sector, particularly in companies like Skye Bioscience [1][2]